News | Digital Radiography (DR) | November 20, 2020

Fujifilm Presents Enhanced DR Solutions with the Availability Glass-free DR detector with ISS Technology

Unique technology to be showcased for healthcare providers at RSNA 2020

Fujifilm Medical Systems U.S.A., Inc., a leading provider of diagnostic imaging and medical informatics solutions, will demonstrate the FDR D-EVO III, an industry-first, glass-free digital radiography (DR) detector with Irradiated Side Sampling (ISS) technology, and the latest additions to Fujifilm's Clinica family digital x-ray suites - FDR Clinica X OTC and FDR Clinica FS – during the 2020 Radiological Society of North America (RSNA) annual meeting.

November 20, 2020 — Fujifilm Medical Systems U.S.A., Inc., a leading provider of diagnostic imaging and medical informatics solutions, will demonstrate the FDR D-EVO III, an industry-first, glass-free digital radiography (DR) detector with Irradiated Side Sampling (ISS) technology, and the latest additions to Fujifilm's Clinica family digital x-ray suites - FDR Clinica X OTC and FDR Clinica FS – during the 2020 Radiological Society of North America (RSNA) annual meeting.

Previewed for the first time at RSNA 2019, the FDR D-EVO III DR detector is now available in 14 x 17 and 17 x 17 sizes across the United States. Engineered to improve detective quantum efficiency (DQE) for clearer images at lower doses, the FDR D-EVO III is currently the lightest 14x17 detector on the market with patented ISS. The groundbreaking detector could be paired with Fujifilm's advanced image processing options, such as Virtual Grid and Dynamic Visualization II.

"Fujifilm is continuing its commitment to deliver innovative solutions by working with customers to learn how we can provide technology solutions that address their needs," said Robert Fabrizio, director of strategic marketing, modality solutions, Fujifilm Medical Systems U.S.A., Inc. "The leap-forward design of FDR D-EVO III provides imaging departments with a smart solution to endure tough medical environments and minimize life cycle costs. Imaging departments will be able to invest in a smart solution, while providing leading-edge technology to their patients that is built to last well into the future."

In addition to the FDR D-EVO III and Fujifilm's line of DR detectors and mobile DR solutions, Fujifilm will spotlight its newest digital X-ray suites during the virtual RSNA show, including:

  • The FDR Clinica X OTC Suite: Overhead mounted system featuring 'grab and go' manual positioning with auto tracking and automated long length stitching at the chest stand, the FDR Clinica X OTC Suite is an affordable DR solution with maximum functionality. Competitive features include a smart display on the X-ray tube head, generator controls integrated into the new FDX One Console acquisition workstation, and built-in detector connections to the rotating DR trays.
  • The FDR Clinica FS: Targeted for orthopedic & ambulatory clinics, imaging centers, private practices and urgent care, the FDR Clinica FS is Fujifilm's latest high-quality, floor mounted cost-effective x-ray solution. The FDR Clinica FS is intended for use with FDR D-EVO II detectors featuring Fujifilm's proprietary ISS technology, which positions its capture electronics (TFTs) at the irradiation side, in contrast to traditional detectors.
  • FDR Visionary Suite: Fujifilm's flagship fully auto-positioning system is getting new updates to step it up to the next generation. Designed to boost x-ray room efficiency, the upgraded FDR Visionary suite offers a variety of enhanced features, including rotating detector tray options, new higher performance x-ray tubes designed for lower noise and extended life, and retractable cables for the overhead tube system. To help speed technologist workflow, the suite also offers an optional new power assist mode (W.I.P.), providing lighter grab and go manual tubes positioning movements for the technologists. For precise imaging, the system is engineered for use with Fujifilm's proprietary ISS detectors to capture images with high sharpness and DQE, and lightning-fast preview and cycle times. The suite will feature new modern colors, is ergonomically designed and easy to operate, with minimal physical effort required so technologists can focus on patient comfort and safety.

"Today's hospitals and healthcare facilities are challenged to deliver rapid imaging exams combined with heightened productivity demands, making it essential that their X-ray systems are able to perform seamlessly," said Rick Banner, Senior Director of Marketing, Modality Solutions, Fujifilm Medical Systems U.S.A., Inc. "Fujifilm's digital suites with advanced features meet that need without compromising image quality and precision."

The FDR Clinica X OTC Suite is not commercially available in the U.S.

Fujifilm's U.S. patented ISS technology is used in its FDR D-EVO and FDR ES detectors.

To learn more information, or book your virtual RSNA demo with Fujifilm, visit https://www.infowebpage.com/FujiRSNA2020/

Related Content

The British Institute of Radiology supports the proposal by AXREM that staff members from private suppliers who work shoulder to shoulder with National Health Service (NHS) staff in high-risk areas in hospitals should be recognised as frontline health and social care staff and prioritised for COVID-19 vaccination accordingly.

Getty Images

News | Coronavirus (COVID-19) | February 12, 2021
February 12, 2021 — The British Institute of Radiology supports the proposal by...
Brazilian researchers found that the higher the lung ultrasound score the greater the risk of ICU admission, intubation and death. Image courtesy of Julio Alencar

Brazilian researchers found that the higher the lung ultrasound score the greater the risk of ICU admission, intubation and death. Image courtesy of Julio Alencar

News | Coronavirus (COVID-19) | February 11, 2021
February 11, 2021 — ...
Unhealthy lifestyles, various diseases, stress, and aging can all contribute to an imbalance between the production of ROS and the body's ability to reduce and eliminate them. The resulting excessive levels of ROS cause "oxidative stress".

Unhealthy lifestyles, various diseases, stress, and aging can all contribute to an imbalance between the production of ROS and the body's ability to reduce and eliminate them. The resulting excessive levels of ROS cause "oxidative stress". Graphic courtesy of National Institutes for Quantum and Radiological Science and Technology

News | Magnetic Resonance Imaging (MRI) | February 10, 2021
February 10, 2021 — Oxygen is essential for human life, but within the body, certain biological environmental conditi
Comparison of breast cancer mortality rates (red squares) and distant-stage breast cancer incidence rates from SEER9 (blue dots) and SEER18 (green dots) per 100,000 for white women aged, A, 20–39, B, 40–69, and, C, 70–79 years (3,7,8).

Comparison of breast cancer mortality rates (red squares) and distant-stage breast cancer incidence rates from SEER9 (blue dots) and SEER18 (green dots) per 100,000 for white women aged, A, 20–39, B, 40–69, and, C, 70–79 years (3,7,8). Image courtesy of Radiology 

News | Breast Imaging | February 10, 2021
February 10, 2021 — Breast cancer death rates have stopped declining for women in the U.S.
 Nuance Communications, Inc. announced the acquisition of Saykara, Inc., a like-minded startup focused on developing a mobile AI assistant to automate clinical documentation for physicians. The acquisition underscores Nuance's ongoing expansion of market and technical leadership in conversational artificial intelligence (AI) and ambient clinical intelligence (ACI) solutions that reduce clinician burnout, enhance patient experiences, and improve overall health system financial integrity.
News | Artificial Intelligence | February 08, 2021
February 8, 2021 — ...

Images in 69-year-old man with biopsy-confirmed Gleason score 7 (3+4) prostate cancer. (a) Pretreatment axial T2-weighted fast spin-echo MRI scan (repetition time msec/echo time msec, 3820/97) shows tumor in midline anterior transition zone (arrow). (b) Intraoperative MRI scan shows contoured rectal wall (red line), prostate margin (blue outline), and region of interest (orange outline). Because the urethra was included in planned treatment volume, a suprapubic catheter was placed for continuous bladder drainage during treatment. (c) Intraoperative MRI scan shows focused ultrasound beam path (blue) overlaid on treatment plan. Rectangles illustrate each sonication spot. (d) Thermal map image obtained during treatment with heat deposition color coded in red overlaid on sonication spot. (e) Axial gadopentetate dimeglumine-enhanced MRI scan (230/2.97) obtained immediately after treatment shows devascularized ablated volume (arrows). (f) Corresponding T2-weighted fast spin-echo MRI scan (3820/97) at 5 months after ablation shows complete involution of transition zone. All seven cores from treatment area margins were negative for cancer at biopsy. Image courtesy of the Radiological Society of North America

News | Prostate Cancer | February 05, 2021
February 5, 2021 — A technique that delivers...